Directory

>

John Lippincott

avatar

John Lippincott

Senior Vice President Therapeutic Discovery Strategies | Alloy Therapeutics, Inc.

San Diego, California, United States

View contact details (it's free)

John Lippincott

Summary

John Lippincott is a seasoned executive with over 20 years of experience in therapeutic discovery strategies, currently serving as the Senior Vice President at Alloy Therapeutics. He has a strong background in antibody generation and characterization, having led significant projects at Pfizer and other biotechnology firms. Lippincott's expertise spans various aspects of biopharmaceuticals, including drug discovery and clinical development. He holds a Ph.D. from Harvard University, where he specialized in Cell Biology. Notably, he has a track record of building and leading high-performing teams in competitive environments. His innovative approach has contributed to advancements in therapeutic candidates and antibody discovery platforms. Lippincott's career reflects a commitment to enhancing the scientific community's ability to develop effective medicines.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Consulting Experience

John Lippincott

Work Experience

company logo

Senior Vice President Therapeutic Discovery Strategies at

Alloy Therapeutics, Inc.

April 2023 - Present

company logo

Senior Vice President of Therapeutic Discovery Strategies at

AlivaMab Biologics

July 2022 - March 2023

company logo

Vice President of Research at

AlivaMab Biologics

March 2018 - July 2022

company logo

Consultant at

Ablexis, LLC

January 2015 - December 2021

company logo

Vice President of Antibody Discovery at

Lakepharma, Inc., Now Part Of Curia

February 2016 - March 2018

company logo

Director of Research Operations at

Ablexis, LLC

March 2012 - January 2015

💼

Director of Antibody Discovery at

IGENICA LIMITED

May 2010 - March 2012

company logo

Senior Principal Scientist at

Pfizer, Inc.

July 2001 - May 2010

company logo

Postdoctoral Associate at

GNF

January 2000 - January 2001

Logos provided by Logo.dev

John Lippincott

Education

Harvard Medical School, Ph.D.

January 1996 - January 2000

University of Washington, Bs

January 1993 - January 1996

University of Washington, Bs

January 1993 - January 1996

Frequently Asked Questions about John Lippincott

What is John Lippincott email address?

John Lippincott's primary email address is ***********@alivamab.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does John Lippincott work for?

John Lippincott is a Senior Vice President Therapeutic Discovery Strategies at Alloy Therapeutics, Inc., a company specializing in Commercial physical research.

Where John Lippincott graduated from?

John Lippincott holds a degree in Cell Biology from Harvard Medical School.

How can I directly contact John Lippincott?

To contact John Lippincott directly, you can use the email address ***********@alivamab.com. Complete contact information is available upon registration with Muraena.

Who is John Lippincott?

John Lippincott is a seasoned executive with over 20 years of experience in therapeutic discovery strategies, currently serving as the Senior Vice President at Alloy Therapeutics. He has a strong background in antibody generation and characterization, having led significant projects at Pfizer and other biotechnology firms. Lippincott's expertise spans various aspects of biopharmaceuticals, including drug discovery and clinical development. He holds a Ph.D. from Harvard University, where he specialized in Cell Biology. Notably, he has a track record of building and leading high-performing teams in competitive environments. His innovative approach has contributed to advancements in therapeutic candidates and antibody discovery platforms. Lippincott's career reflects a commitment to enhancing the scientific community's ability to develop effective medicines.

John`s contact details

mail

***********@alivamab.com

***************@alloytx.com

*****@post.harvard.edu

Colleagues

avatar
Mike Schmidt

General Partner

avatar
Dongxing Zha

CTO, TCR Discovery and Engineering at Alloy Therapeutics | Founder and CEO at Keyway TCR Discovery

avatar
Casey Matthews

Vice President of Daedamab Business Development

avatar
Heather Schwoebel

Harvard Business Review Advisory Council Member

avatar
Zhiqian Lucy Liu

VP Head of Protein Science & Bioanalytics

View Contact details (it's free)
Request Profile Removal